Skip to main content
Top
Published in: Supportive Care in Cancer 2/2019

01-02-2019 | Original Article

Clinical and epidemiological factors associated with suicide in colorectal cancer

Authors: Thuy T. Pham, Asif M. Talukder, Nathaniel J. Walsh, Andrew G. Lawson, Andrew J. Jones, Jessica L. Bishop, Edward J. Kruse

Published in: Supportive Care in Cancer | Issue 2/2019

Login to get access

Abstract

Purpose

While increased suicidal tendencies among cancer patients have been well documented, this study aims to examine suicide rates and factors associated with suicide specifically in patients with colorectal cancer (CRC).

Methods

Patients diagnosed with CRC between the years of 1988–2010 were selected from the Surveillance, Epidemiology, and End Result (SEER) database. Comparisons with the general population were done using the National Center for Disease Control registry.

Results

One thousand three hundred eighty-one suicides among 884,529 patients were identified, with a standardized mortality ratio (SMR) of 1.53 (95% CI, 1.13–1.33) compared to the general population. No statistically significant difference in suicide rate was found with respect to age, marital status, socio-economic status, surgical intervention, histologic subtype, or stage at diagnosis. Within the CRC population, Whites were significantly more likely to commit suicide than non-Whites (OR, 2.28; 95% CI, 1.89–2.75; P < 0.001), and males were significantly more likely than females (OR, 5.635; 95% CI, 4.85–6.54; P < 0.001). Most suicides occurred in patients with distal lesions in the sigmoid/rectosigmoid junction (P < 0.001). SMRs for CRC patients were 4.24 for females (95% CI, 3.69–4.86), 1.35 for males (95% CI, 1.28–1.43), 0.38 for African-Americans (95% CI, 0.28–0.52), 1.77 for Whites (95% CI, 1.68–1.87), and 0.90 for other races (95% CI, 0.72–1.12).

Conclusion

Identification of risk factors associated with suicide among patients with CRC is an important step in developing screening strategies and management of psychosocial stressors. These results could be helpful in formulating a comprehensive suicide risk scoring system for screening all cancer patients.
Literature
2.
go back to reference American Cancer Society (2014) Cancer facts & figures 2014. Am Cancer Soc American Cancer Society (2014) Cancer facts & figures 2014. Am Cancer Soc
4.
go back to reference Greenberg DB (2011) The signal of suicide rates seen from a distance in patients with pancreatic cancer. Cancer 117(3):446–448CrossRef Greenberg DB (2011) The signal of suicide rates seen from a distance in patients with pancreatic cancer. Cancer 117(3):446–448CrossRef
5.
go back to reference Ahn MH, Park S, Lee HB et al (2015) Suicide in cancer patients within the first year of diagnosis. Psycho-Oncology 24(5):601–607CrossRef Ahn MH, Park S, Lee HB et al (2015) Suicide in cancer patients within the first year of diagnosis. Psycho-Oncology 24(5):601–607CrossRef
6.
go back to reference Johnson TV, Garlow SJ, Brawley OW, Master VA (2012) Peak window of suicides occurs within the first month of diagnosis: implications for clinical oncology. Psycho-Oncology 21(4):351–356CrossRef Johnson TV, Garlow SJ, Brawley OW, Master VA (2012) Peak window of suicides occurs within the first month of diagnosis: implications for clinical oncology. Psycho-Oncology 21(4):351–356CrossRef
7.
go back to reference Vyssoki B, Gleiss A, Rockett IRH et al (2015) Suicide among 915,303 Austrian cancer patients: who is at risk? J Affect Disord 175:287–291CrossRef Vyssoki B, Gleiss A, Rockett IRH et al (2015) Suicide among 915,303 Austrian cancer patients: who is at risk? J Affect Disord 175:287–291CrossRef
8.
go back to reference de la Grandmaison GL, Watier L, Cavard S, Charlier P (2014) Are suicide rates higher in the cancer population? An investigation using forensic autopsy data. Med Hypotheses 82(1):16–19CrossRef de la Grandmaison GL, Watier L, Cavard S, Charlier P (2014) Are suicide rates higher in the cancer population? An investigation using forensic autopsy data. Med Hypotheses 82(1):16–19CrossRef
9.
go back to reference Smailyte G, Jasilionis D, Kaceniene A, Krilaviciute A, Ambrozaitiene D, Stankuniene V (2013) Suicides among cancer patients in Lithuania: a population-based census-linked study. Cancer Epidemiol 37(5):714–718CrossRef Smailyte G, Jasilionis D, Kaceniene A, Krilaviciute A, Ambrozaitiene D, Stankuniene V (2013) Suicides among cancer patients in Lithuania: a population-based census-linked study. Cancer Epidemiol 37(5):714–718CrossRef
10.
go back to reference Yamauchi T, Inagaki M, Yonemoto N et al (2014) Death by suicide and other externally caused injuries following a cancer diagnosis: the Japan public health center-based prospective study. Psycho-Oncology 23(9):1034–1041CrossRef Yamauchi T, Inagaki M, Yonemoto N et al (2014) Death by suicide and other externally caused injuries following a cancer diagnosis: the Japan public health center-based prospective study. Psycho-Oncology 23(9):1034–1041CrossRef
12.
go back to reference Renee Twombly; Decades after cancer, suicide risk remains high, JNCI: Journal of the National Cancer Institute, Volume 98, Issue 19, 4 October 2006, Pages 1356–1358 Renee Twombly; Decades after cancer, suicide risk remains high, JNCI: Journal of the National Cancer Institute, Volume 98, Issue 19, 4 October 2006, Pages 1356–1358
13.
go back to reference Klaassen Z, Jen RP, DiBianco JM et al (2015) Factors associated with suicide in patients with genitourinary malignancies. Cancer 121(11):1864–1872CrossRef Klaassen Z, Jen RP, DiBianco JM et al (2015) Factors associated with suicide in patients with genitourinary malignancies. Cancer 121(11):1864–1872CrossRef
14.
go back to reference Riblet N, Larson R, Watts BV, Holtzheimer P (2014) Reevaluating the role of antidepressants in cancer-related depression: a systematic review and meta-analysis. Gen Hosp Psychiatry 36(5):466–473CrossRef Riblet N, Larson R, Watts BV, Holtzheimer P (2014) Reevaluating the role of antidepressants in cancer-related depression: a systematic review and meta-analysis. Gen Hosp Psychiatry 36(5):466–473CrossRef
15.
go back to reference Oberaigner W, Sperner-Unterweger B, Fiegl M, Geiger-Gritsch S, Haring C (2014) Increased suicide risk in cancer patients in Tyrol/Austria. Gen Hosp Psychiatry 36(5):483–487CrossRef Oberaigner W, Sperner-Unterweger B, Fiegl M, Geiger-Gritsch S, Haring C (2014) Increased suicide risk in cancer patients in Tyrol/Austria. Gen Hosp Psychiatry 36(5):483–487CrossRef
16.
go back to reference Cole TB, Bowling JM, Patetta MJ, Blazer DG (2014) Risk factors for suicide among older adults with cancer. Aging Ment Health 18(7):854–860 857pCrossRef Cole TB, Bowling JM, Patetta MJ, Blazer DG (2014) Risk factors for suicide among older adults with cancer. Aging Ment Health 18(7):854–860 857pCrossRef
17.
go back to reference Panczak R, Spoerri A, Zwahlen M, Bopp M, Gutzwiller F, Egger M (2013) Religion and suicide in patients with mental illness or cancer. Suicide Life Threat Behav 43(2):213–222CrossRef Panczak R, Spoerri A, Zwahlen M, Bopp M, Gutzwiller F, Egger M (2013) Religion and suicide in patients with mental illness or cancer. Suicide Life Threat Behav 43(2):213–222CrossRef
18.
go back to reference Erlangsen A, Stenager E, Conwell Y (2015) Physical diseases as predictors of suicide in older adults: a nationwide, register-based cohort study. Soc Psychiatry Psychiatr Epidemiol 50(9):1427–1439CrossRef Erlangsen A, Stenager E, Conwell Y (2015) Physical diseases as predictors of suicide in older adults: a nationwide, register-based cohort study. Soc Psychiatry Psychiatr Epidemiol 50(9):1427–1439CrossRef
19.
go back to reference Surveillance Epidemiology and End Results (SEER) program: public-use data (1988–2010). Bethesda, MD, National Cancer Institute, 2016 Surveillance Epidemiology and End Results (SEER) program: public-use data (1988–2010). Bethesda, MD, National Cancer Institute, 2016
20.
go back to reference Surveillance Epidemiology and End Results: mortality–all COD, public-use with state, total US (1988–2010), Surveillance, Epidemiology, and End Results (SEER) Program SEER*Stat Database. Bethesda, MD, National Cancer Institute, 2016 Surveillance Epidemiology and End Results: mortality–all COD, public-use with state, total US (1988–2010), Surveillance, Epidemiology, and End Results (SEER) Program SEER*Stat Database. Bethesda, MD, National Cancer Institute, 2016
21.
go back to reference U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999–2014 Incidence and Mortality Web-based report. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2017 U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999–2014 Incidence and Mortality Web-based report. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2017
22.
go back to reference Ury HK, Wiggins AD (1985) Another shortcut method for calculating the confidence interval of a Poisson variable (or of a standardized mortality ratio). Am J Epidemiol 122:197–198CrossRef Ury HK, Wiggins AD (1985) Another shortcut method for calculating the confidence interval of a Poisson variable (or of a standardized mortality ratio). Am J Epidemiol 122:197–198CrossRef
23.
go back to reference Komic A, Taludker A, Walsh N, Jones A, Lawson A, Bateson B, Kruse EJ (2017) Suicide risk in melanoma: what do we know? Am Surg 83(11):435–437 Komic A, Taludker A, Walsh N, Jones A, Lawson A, Bateson B, Kruse EJ (2017) Suicide risk in melanoma: what do we know? Am Surg 83(11):435–437
24.
go back to reference Walsh, NJ, Taludker, AM, Lawson, AG, Komic, AX, Bateson, BP, Jones, A, Kruse, EJ Thyroid malignancy and suicide risk: an analysis of epidemiologic and clinical factors. Accepted for print in: World Journal of Endocrine Surgery. 2018 Walsh, NJ, Taludker, AM, Lawson, AG, Komic, AX, Bateson, BP, Jones, A, Kruse, EJ Thyroid malignancy and suicide risk: an analysis of epidemiologic and clinical factors. Accepted for print in: World Journal of Endocrine Surgery. 2018
25.
go back to reference Majumdar SR, Fletcher RH, Evans AT (1999) How does colorectal cancer present? Symptoms, duration, and clues to location. Am J Gastroenterol 94(10):3039–3045CrossRef Majumdar SR, Fletcher RH, Evans AT (1999) How does colorectal cancer present? Symptoms, duration, and clues to location. Am J Gastroenterol 94(10):3039–3045CrossRef
26.
go back to reference Ravasco P, Monteiro-Grillo I, Vidal PM et al (2004) Cancer: disease and nutrition are key determinates in patients’ quality of life. Support Care Cancer 12:246CrossRef Ravasco P, Monteiro-Grillo I, Vidal PM et al (2004) Cancer: disease and nutrition are key determinates in patients’ quality of life. Support Care Cancer 12:246CrossRef
27.
go back to reference Miller M, Azrael D, Hemingway D (2004) The epidemiology of case fatality rates for suicide in the northeast. Ann Emerg Med 43:723–730CrossRef Miller M, Azrael D, Hemingway D (2004) The epidemiology of case fatality rates for suicide in the northeast. Ann Emerg Med 43:723–730CrossRef
28.
go back to reference Rehse B, Pukrop R (2003) Effects of psychosocial interventions on quality of life in adult cancer patients: meta analysis of 37 published controlled outcome studies. Patient Educ Couns 50:179–186CrossRef Rehse B, Pukrop R (2003) Effects of psychosocial interventions on quality of life in adult cancer patients: meta analysis of 37 published controlled outcome studies. Patient Educ Couns 50:179–186CrossRef
Metadata
Title
Clinical and epidemiological factors associated with suicide in colorectal cancer
Authors
Thuy T. Pham
Asif M. Talukder
Nathaniel J. Walsh
Andrew G. Lawson
Andrew J. Jones
Jessica L. Bishop
Edward J. Kruse
Publication date
01-02-2019
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 2/2019
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-018-4354-3

Other articles of this Issue 2/2019

Supportive Care in Cancer 2/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine